| Title | Advances in Experimental Medicine and Biology |
| Abbreviation | Adv. Exp. Med. Biol. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Medicine (miscellaneous) (Q3) |
| h-index | 142 |
| Overall Rank/Ranking | 12237 |
| SCImago Journal Rank (SJR) | 0.410 |
| Impact Score | 2.81 |
| Publisher | Springer New York |
| Country | United States |
| ISSN | 00652598 |
| Best Quartile | Q3 |
| Coverage History | 1971-2022 |
Advances in Experimental Medicine and Biology is a journal covering the technologies/fields/categories related to Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Medicine (miscellaneous) (Q3). It is published by Springer New York. The overall rank of Advances in Experimental Medicine and Biology is 12237. According to SCImago Journal Rank (SJR), this journal is ranked 0.410. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 142. The best quartile for this journal is Q3.
The ISSN of Advances in Experimental Medicine and Biology journal is 00652598. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Advances in Experimental Medicine and Biology is cited by a total of 13179 articles during the last 3 years (Preceding 2022).
The Impact IF 2022 of Advances in Experimental Medicine and Biology is 2.81, which is computed in 2023 as per its definition. Advances in Experimental Medicine and Biology IF is decreased by a factor of 0.6 and approximate percentage change is -17.6% when compared to preceding year 2021, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2022 of Advances in Experimental Medicine and Biology is 2.81. If the same downward trend persists, Impact IF may fall in 2023 as well.
| Year | Impact IF |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 2.81 |
| 2021 | 3.41 |
| 2020 | 2.34 |
| 2019 | 2.06 |
| 2018 | 1.79 |
| 2017 | 1.65 |
| 2016 | 2.10 |
| 2015 | 2.27 |
| 2014 | 2.24 |
Advances in Experimental Medicine and Biology has an h-index of 142. It means 142 articles of this journal have more than 142 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Advances in Experimental Medicine and Biology is 00652598. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Advances in Experimental Medicine and Biology is 12237. According to SCImago Journal Rank (SJR), this journal is ranked 0.410. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 0.410 |
| 2021 | 0.398 |
| 2020 | 0.529 |
| 2019 | 0.678 |
| 2018 | 0.646 |
| 2017 | 0.867 |
| 2016 | 0.879 |
| 2015 | 0.998 |
| 2014 | 1.050 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 12237 |
| 2021 | 12110 |
| 2020 | 9546 |
| 2019 | 7194 |
| 2018 | 7457 |
| 2017 | 5265 |
| 2016 | 5201 |
| 2015 | 4456 |
| 2014 | 4039 |
Advances in Experimental Medicine and Biology is published by Springer New York. It's publishing house is located in United States. Coverage history of this journal is as following: 1971-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Advances in Experimental Medicine and Biology is Adv. Exp. Med. Biol.. This abbreviation ('Adv. Exp. Med. Biol.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Medicine (miscellaneous) (Q3), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Advances in Experimental Medicine and Biology latest impact IF is 2.81. It's evaluated in the year 2022. The highest and the lowest impact IF or impact score of this journal are 3.41 (2021) and 1.65 (2017), respectively, in the last 9 years. Moreover, its average IS is 2.3 in the previous 9 years.
The Advances in Experimental Medicine and Biology has an SJR (SCImago Journal Rank) of 0.410, according to the latest data. It is computed in the year 2023. In the past 9 years, this journal has recorded a range of SJR, with the highest being 1.050 in 2014 and the lowest being 0.398 in 2021. Furthermore, the average SJR of the Advances in Experimental Medicine and Biology over the previous 9-year period stands at 2.3.
The latest h-index of the Advances in Experimental Medicine and Biology is 142.
The Advances in Experimental Medicine and Biology is published by the Springer New York, with its country of publication being the United States.
The Advances in Experimental Medicine and Biology is currently ranked 12237 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 4039 in 2014 and its lowest position of 12237 in 2022.
The standard ISO4 abbreviation for the Advances in Experimental Medicine and Biology is Adv. Exp. Med. Biol..
Advances in Experimental Medicine and Biology is classified as a journal that the Springer New York publishes.
The Advances in Experimental Medicine and Biology encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Advances in Experimental Medicine and Biology is assigned the following International Standard Serial Numbers (ISSN): 00652598.
The best quartile for the Advances in Experimental Medicine and Biology is Q3 (2022).
The Advances in Experimental Medicine and Biology coverage history can be summarized as follows: 1971-2022.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Canadian Journal of Education | journal | 17961 | Canadian Society for the Study of Education (CSSE) | 41 | 0.39 |
| Proceedings of the International Semiconductor Conference, CAS | conference and proceedings | 25734 | Institute of Electrical and Electronics Engineers Inc. | 16 | 0.00 |
| Oral Radiology | journal | 9461 | Springer Japan | 20 | 2.06 |
| SPE International Formation Damage Control Symposium Proceedings | conference and proceedings | 21934 | 16 | 0.00 | |
| Clinical Interventions in Aging | journal | 4777 | Dove Medical Press Ltd. | 96 | 3.57 |
| Physica Status Solidi - Rapid Research Letters | journal | 6699 | Wiley-VCH Verlag | 76 | 2.77 |
| Innovations in Pharmaceutical Technology | trade journal | 26994 | Samedan Ltd | 9 | 0.00 |
| Brain Imaging and Behavior | journal | 4198 | Springer New York | 62 | 3.56 |
| Revista do Colegio Brasileiro de Cirurgioes | journal | 16407 | Colegio Brasileiro de Cirurgioes | 26 | 0.82 |
| Endangered Species Research | journal | 4658 | Inter-Research | 66 | 3.20 |
| Year | Impact Score (IS) |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 2.81 |
| 2021 | 3.41 |
| 2020 | 2.34 |
| 2019 | 2.06 |
| 2018 | 1.79 |
| 2017 | 1.65 |
| 2016 | 2.10 |
| 2015 | 2.27 |
| 2014 | 2.24 |
